Currently launching Cobenfy, for the treatment of Adults living with Schizophrenia to providers, care teams, pharmacists and small hospitals who treat patients in the CMHC setting.
- #1MHAS in the country since 10/24. Recognized with The Jump-in Award at NSM March 2025.
- Drive RX utilization thru decision makers, prescribers and non-prescribers in CMHC setting by addressing the specific need of the patient, prescriber and bigger organizational picture. Continuously update account mapping to enure all influencers are accounted for to allow for identification, drive and protection of Cobenfy prescriptions as well as appropriate reach and frequency.
- Coordinate with 5 TAS partners to enure seamless targeting, call continuum and prescription adoption while effectively utilizing resources such as MSL's, RMK's and speakers. Carefully manage 40 accounts in 3 different states, demonstrating exceptional organizational skills and attention to detail.
- Quickly built strong relationships with clients through value driven, direct communication and proactive problem-solving efforts to allow them to quickly identify patients and get experience with Cobenfy.
- West Area MHAS DST. Currently leading book club on leveraging influence with partners and providers. Co-facilitatating a Challenger Selling workshop and proactively built and facilitated a workshop on negative symptoms in Schizophrenia. Currently leading collaboration calls with the East MAHS team to share ideas and drive results. Team members express excellent feedback and the continue the meetings. Workshop facilitation at the March national meeting.